Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Anhydrous Citric Acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 9 USDMF, 1 CEP/COS, 4 JDMF, 2 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

57 Drugs in Development

57 Drugs in Development

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers, 9 FDA Orange Book, 41 Europe, 51 Canada, 10 Australia, 7 South Africa, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;IRRIGATION - 6.602GM/100ML;198MG/100ML;3.177GM/100ML, FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 10 Rochem International Inc, 16 SPI Pharma, 12 DKSH, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 7 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 22 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 2 Clariant, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Esteem Industries, 2 Finar, 8 Gangwal Chemicals, 5 Ideal Cures, 1 Ingredion Pharma Solutions, 13 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 23 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 38 Thickeners and Stabilizers, 27 Taste Masking, 26 Controlled & Modified Release, 26 Parenteral, 25 Topical, 22 Direct Compression, 20 Film Formers & Plasticizers, 18 Solubilizers, 17 Chewable & Orodispersible Aids, 17 Granulation, 16 Lubricants & Glidants, 12 Disintegrants & Superdisintegrants, 10 Co-Processed Excipients, 9 Empty Capsules, 8 Rheology Modifiers, 7 Emulsifying Agents, 6 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 22 News #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 10 Regulatory FDF Prices

MARKET PLACE

29 APIs, 1 FDF Dossiers, 15 EXCIPIENTS, 1 Intermediates

PATENTS & EXCLUSIVITIES

9 US Patents

9 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/10/2025	Jungbunzlauer International AG	Switzerland	JUNGBUNZLAUER LADENBURG GMBH Ladenburg DE	CEP 2016-005 - Rev 03	Citric acid, non-micronised and micronised	2025-01-23	Valid	Chemical		455

Anhydrous Citric Acid

Anhydrous Citric Acid

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers

9 USDMF

1 CEP/COS

4 JDMF

2 NDC API

11 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

57 Drugs in Development

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers

9 FDA Orange Book

41 Europe

51 Canada

10 Australia

7 South Africa

2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;IRRIGATION - 6.602GM/100ML;198MG/100ML;3.177GM/100ML

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

2 EUROAPI

10 Rochem International Inc

16 SPI Pharma

12 DKSH

2 Pharm-RX Chemical

1 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

7 Kirsch Pharma

4 ACG Worldwide

11 Actylis

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 Avesta Pharma

22 BASF

1 Bioplus Life Sciences

2 CD Formulation

2 Clariant

10 Corel Pharma Chem

2 DFE Pharma

1 Esteem Industries

2 Finar

8 Gangwal Chemicals

5 Ideal Cures

1 Ingredion Pharma Solutions

13 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

2 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

23 Roquette

8 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

2 Silverline Chemicals

2 The Dow Chemical Company

1 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons